Lantis Laser's Dental Imaging Technology Could Reduce Incidence of Root Canal
Therapy Failures
DENVILLE, N.J., Jan. 7, 2008 (PRIME NEWSWIRE) -- Lantis Laser Inc. (Pink
Sheets:LLSR) (http://www.lantislaser.com) reports that researchers have shown
that optical coherence tomography (OCT), a novel light-based bio-medical imaging
technology, has the ability to characterize the root canal walls during therapy.
The research by Dr Hagay Shemesh et al at the Academic Centre for Dentistry in
Amsterdam, The Netherlands was published as the feature article in the Journal
of Endodontics November 2007 issue. Using a real-time chairside OCT imaging
system, dentists could view the root canal after preparation to ensure that
possible causes of treatment failure have been eliminated as much as possible.
"This is a very exciting and significant expansion of the application of OCT in
dentistry," commented Dr Craig Gimbel, Vice-President Clinical Affairs at
Lantis. "Currently dentists have no means of viewing the canal in detail and
this research clearly shows that OCT could become the gold standard for
characterizing perforations, cracks or other imperfections in the canal that
contribute to treatment failure."
The paper clearly demonstrated the ability of OCT to image root canal walls
after endodontic preparation and to correlate the OCT images with histologic
sections to validate the integrity of the OCT imaging system. The conclusion of
the study was that OCT proved to be reliable method to image root canal tissue
in a non-destructive way.
Lantis is currently preparing its OCT Dental Imaging System(tm) for deployment
in clinical use. In order to commercialize the endodontic application Lantis is
designing and building the special rotary scanner that is required for the
endodontic application. Lantis intends to work closely with Dr Shemesh and ACTA
to fully realize the potential of OCT in endodontics.
Stan Baron, President and CEO of Lantis said, "This research shows that the
application of OCT in dentistry enables dentists to obtain views of tissue that
have been hitherto unobtainable. Once in the hands of dentists many other
applications, apart from the early detection of oral diseases such as decay,
will become evident and show that OCT will become indispensable in the dental
office as it raises imaging and diagnostics to a new level."
About Lantis Laser
Lantis was formed to commercialize the application of novel technologies in the
dental industry. The criteria for selected products include competitive edge,
exclusivity and large market potential. Lantis is currently in Phase 2
development and plans to launch the OCT Dental Imaging System(tm) in the third
quarter of 2008. Lantis has exclusive rights to the application of OCT
technology in the field of dentistry under its license Agreements with Lawrence
Livermore National Laboratory and LightLab Imaging. OCT was invented in the
early 1990's at the Massachusetts Institute of Technology and is currently being
commercialized by Carl Zeiss Meditec, Inc. in ophthalmology and by LightLab
Imaging for cardiovascular imaging.
To find out more about Lantis Laser (Pink Sheets:LLSR) visit our website at
www.lantislaser.com
Forward-Looking Statements:
Certain statements in this press release, including statements regarding the
anticipated development and expansion of Lantis' business, and the intent,
belief or current expectations of Lantis, its directors or its officers, are
forward-looking statements. Because such statements are subject to risks and
uncertainties, actual results may differ materially from those expressed or
implied by such forward-looking statements.
-0-
CONTACT: Lantis Laser Inc.
Stan Baron, President & CEO
(203) 300-7622
sbaron@lantislaser.com
Investor Relations
AGORACOM Investor Relations
http://www.agoracom.com/IR/lantislaser
llsr@agoracom.com
